In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition

Simple item page
dc.contributor.authorQi Guo
dc.contributor.authorJian Zhang
dc.contributor.authorKeval Parikh
dc.contributor.authorAlexander Brinkley
dc.contributor.authorSamantha Lin
dc.contributor.authorChristina Zakarian
dc.contributor.authorOlivier Pernet
dc.contributor.authorSaki Shimizu
dc.contributor.authorWannisa Khamaikawin
dc.contributor.authorKatrin Hacke
dc.contributor.authorNoriyuki Kasahara
dc.contributor.authorDong Sung An
dc.date.accessioned2026-05-08T19:19:20Z
dc.date.issued2023-12-11
dc.identifier.doi10.1016/j.ymthe.2023.12.007
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/16974
dc.publisherMolecular Therapy
dc.subjectVirus-based gene therapy research
dc.subjectHIV Research and Treatment
dc.subjectCAR-T cell therapy research
dc.titleIn vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition
dc.typeArticle

Files

Collections

All